What Could Happen if Film Studios Owned Their Own Theaters: Ratified

 

On this episode of Ratified, MarketScale’s podcast on the intersection of policy and business, Voice of B2B Daniel Litwin takes a trip back in time – and to the modern-day legal battleground emerging under President Trump’s DOJ – to examine the 1948 Paramount Decision.

To get you up to speed, that 1948 decision by the U.S. Supreme Court came about in a time when block-cooking, blind-buying and circuit dealing were rampant in the film industry. Litwin goes into exactly what those terms mean, but the gist is this – vertical integration in the film industry was dominant, and major companies created monopolies and stifled competition.

An initial suit in 1938 bloomed into the 1948 decision, which saw the Supreme Court rule that film studios could no longer legally own their own theaters. This led to a boom for independent theaters and creators.

Now, the Department of Justice is looking to reverse course on the decades-old ruling.

Essentially, the argument boils down to this – the Antitrust Division of the DOJ believes these restrictions are no longer relevant in a media landscape that has so drastically shifted away from the theater experience of even a decade or two ago.

To examine the implications of a potential rollback, Litwin welcomed the University of Southern California’s Dr. John Connor to get some historical perspective, highlight economic structures in modern filmmaking and distribution, where independent media would go in the wake of a reversal, and more.

UCLA School of Theater, Film and Television’s Tom Nunan, former president of NBC Studios, among a laundry list of high-profile roles in the film industry, also joined the program to bring insights from the perspective of the country’s largest studios.

Listen to all episodes of Ratified.

For the latest news, videos, and podcasts in the Sports & Entertainment Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

pcp
PCP Attribution Analysis
May 22, 2025

Dr. Sam Ambewadikar, RVP and Medical Director at Anthem National Accounts, joins Brent to unpack the power of primary care attribution analysis—a tool he helped pioneer to spotlight the clinical and financial impact of members not having an established PCP. Drawing from his background as a practicing pediatrician and claims analytics leader, Dr. Sam shares…

Read More
sydney health
Sydney Health Demo
May 22, 2025

In this episode, Christina Firouztash, Executive Advisor of Digital Solutions at Anthem, gives a dynamic walkthrough of the Sydney Health app—Anthem’s flagship digital member experience. Christina showcases how Sydney delivers personalized, simple, and equitable navigation across benefits, including virtual care, pharmacy, financial transparency, and social services access. From contextual chatbots and ID card access to…

Read More
pharmacy
Pharmacy Part 1
May 22, 2025

In this episode, Brent chats with Katie Brennan, National Sales Director at CarelonRx, about making pharmacy benefits more accessible, consistent, and member-friendly. Katie spotlights Carelon new advanced home delivery model, which brings the pharmacy counter—and the pharmacist—into the member’s home. With fewer retail pharmacies offering extended hours and many patients lacking reliable transportation, CarelonRx is…

Read More
inclusive care
Inclusive Care
May 22, 2025

Sammy Gonzalez, Regional Vice President at Elevance Health, joins Brent for a deeply personal and impactful conversation on health equity and inclusive care. Sammy shares a powerful story of medical misdiagnosis tied to cultural assumptions, underscoring how bias—even unintentional—can hinder care quality. He highlights Elevance’s work to improve diversity in provider networks, enhance cultural competency,…

Read More